The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients-Reference-Cited by-同舟云学术

The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients

Published:2008-04 Issue:2 Volume:35 Page:153-157
ISSN:1744-3121
Container-title:International Journal of Immunogenetics
language:en
Short-container-title:Int J Immunogenet

Author:

Chen P.-J.,Hwang Y.,Lin C. G.-J.,Wu Y.-J.,Wu L. S.-H.

Publisher

Wiley

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-313X.2008.00754.x/fullpdf

Reference20 articles.

1. Management of hepatitis C

2. Hepatology highlights

3. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT

4. Genome Screens Using Linkage Disequilibrium Tests: Optimal Marker Characteristics and Feasibility

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of CD81 and SCARB1 polymorphisms on virological responses in Iranian patients with chronic hepatitis C virus genotype 1;Infection, Genetics and Evolution;2018-08

2. Effect of IL15 rs10833 and SCARB1 rs10846744 on virologic responses in chronic hepatitis C patients treated with pegylated interferon-α and ribavirin;Gene;2017-09

3. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection;Liver International;2016-03-14

4. Research Highlights: Pharmacogenomics of chronic hepatitis C;Pharmacogenomics;2009-06

5. Nomenclature for factors of the HLA system, update February 2008;Tissue Antigens;2008-06